Precision Medicine

By Bill Siwicki 10:30 am January 07, 2020
Three experts from different areas of the health IT field discuss how artificial intelligence is going to play a larger role in the year ahead.
By Nathan Eddy 10:10 am January 07, 2020
A study published in Nature suggests its model was able to spot cancer in de-identified screening mammograms with fewer false positives and false negatives than experts.
By Mike Miliard 01:19 pm January 06, 2020
The pharma company will work with MIT's School of Engineering to establish an education program focused on developing new machine learning approaches to drug development and more.
By Nathan Eddy 02:53 pm December 18, 2019
BioLabs@NYU Langone, billed as the largest of its kind in New York City, will house more than 35 early-stage biotechnology and life sciences companies and 160 scientists and staff.
By Nathan Eddy 12:26 pm November 27, 2019
The center will use precision genomics to discover, address and treat genetic diseases, many of which affect infants and children and can cause life-long disability.
Mount Sinai to build new precision medicine supercomputer
By Mike Miliard 03:49 pm November 18, 2019
The health system's second "big omics data engine," or BODE 2, funded in part by HHS, will have 15 terabytes of memory, 14 petabytes of raw storage and a peak speed of 220 teraflops per second – nearly double that of its predecessor.

JAX Genomic Medicine in Farmington, Connecticut. (photo: JAX.org)

By Mike Miliard 11:21 am October 29, 2019
Genomic medicine researchers at the laboratory have been using artificial intelligence, developed as part of Microsoft's Project Hanover, to help manage the vast amount of research data needed to power its precision oncology initiatives.
Jefferson Health combines genomics, population health to enhance employee wellness

Jefferson Health.

By Bill Siwicki 11:38 am October 24, 2019
More than 30% of the health system’s employees have signed up for a precision medicine program that helps get predictive genomics data straight to frontline caregivers.
By Benjamin Harris 11:00 am October 10, 2019
By enabling board members to review clinical trial treatment options virtually, assessment time can be reduced from 14 days to four, according to a new study in the Journal of the American Medical Informatics Association.
The long view of pharma and digital health
By Bill Siwicki 01:43 pm October 02, 2019
At the HIMSS Connected Health Conference, Bob Coughlin, president and CEO of Mass Biotech Council, offers his expert view of how these two areas of healthcare will impact each other in the future.